phs000280.v5.p1 Atherosclerosis Risk in Communities (ARIC) Cohort | Versions 1-5: passed embargo
| VDAS | 15678 | Longitudinal, Cohort | | |
phs000017.v3.p1 Whole Genome Association Study of Bipolar Disorder | Versions 1-3: passed embargo
| VDAS | 3261 | Case-Control | Links | AFFY_6.0
|
phs000007.v30.p11 Framingham Cohort | Versions 1-30: passed embargo
| VDAS | 15154 | Longitudinal | | HuGeneFocused50K_Affy Mapping250K_Nsp Mapping250K_Sty Mapping50K_Hind240 Mapping50K_Xba240
|
phs000090.v4.p1 GENEVA: The Atherosclerosis Risk in Communities (ARIC) Study | Versions 1-4: passed embargo
| VDAS | 12771 | Case-Control | | AFFY_6.0
|
phs000228.v4.p1 HMP Core Microbiome Sampling Protocol A (HMP-A) | Versions 1-4: passed embargo
| VDAS | 300 | Population-Based Control Set | Links | 454 GS FLX Titanium 454 GS FLX Titanium
|
phs000363.v17.p11 NHLBI Framingham SABRe CVD | Versions 1-17: passed embargo
| VDAS | 7558 | Cohort | | GeneChip Human Exon 1.0 ST Array Custom Panel TaqMan 350 MicroRNA Custom Panels
|
phs000742.v1.p1 The Epilepsy Phenome/Genome Project | Version 1: passed embargo
| VDAS | 5538 | Parent-Offspring Trios, Parent-Offspring | Links | |
phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) Cohort | Versions 1-13: passed embargo
| VDAS | 8296 | Longitudinal, Family | Links | |
phs000285.v3.p2 CARDIA Cohort | Versions 1-3: passed embargo
| VDAS | 3622 | Longitudinal | Links | |
phs000578.v1.p1 Nondystrophic Myotonias | Version 1: passed embargo
| VDAS | 95 | Longitudinal | Links | |
phs000086.v3.p1 DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes | Versions 1-3: passed embargo
| VDAS | 1497 | Clinical Trial, Longitudinal | Links | HumanHap550v3.0 ILLUMINA_Human_1M
|
phs000391.v1.p1 Pharmacogenomics of Anti-Platelet Intervention (PAPI) Study | Version 1: passed embargo
| VDAS | 666 | Interventional | Links | Mapping250K_Nsp Mapping250K_Sty AFFY_6.0
|
phs000200.v12.p3 Women's Health Initiative | Versions 1-11: passed embargo Version 12:
| VDAS | 143213 | Partial Factorial Randomized, Double-Blind, Placebo-Controlled, Cohort, Longitudinal | Links | |
phs001575.v1.p1 Assessment of Neurological Deterioration in Subjects with LINCL | Version 1: passed embargo
| VDAS | 42 | Longitudinal | | |
phs000309.v3.p2 The CARDIA-GENEVA Study | Versions 1-3: passed embargo
| VDAS | 1926 | Longitudinal | Links | AFFY_6.0
|
phs000236.v2.p2 PAGE: CALiCo: Coronary Artery Risk Development in Young Adults(CARDIA) | Versions 1-2: passed embargo
| VDAS | 3595 | Longitudinal | Links | TaqMan OpenArrays: CALiCo ABD TaqMan Y1 TaqMan OpenArrays: CALiCo ABD TaqMan Y2 TaqMan OpenArrays: CALiCo AOD TaqMan Y1 TaqMan OpenArrays: CALiCo AOD TaqMan Y2 TaqMan OpenArrays: CALiCo DME TaqMan Y1 TaqMan OpenArrays: CALiCo DME TaqMan Y2 TaqMan OpenArrays: CALiCo Sequenom Y2 iSelect Custom Panel
|
phs001584.v1.p1 eMERGE Network Phase III: HRC Imputed Array Data of 83,000+ Participants | Version 1: passed embargo
| VDAS | 83717 | Case-Control | | Nimblegen Custom SeqCap
|
phs000888.v1.p1 eMERGE Network Imputed GWAS for 41 phenotypes | Version 1: passed embargo
| VDAS | 55029 | Case-Control, Cohort | Links | 1000 Genomes
|
phs000914.v1.p1 Genome-wide Association Study of Adiposity in Samoans | Version 1: passed embargo
| VDAS | 3501 | Cross-Sectional, Population | Links | AFFY_6.0
|